As of April 2024 Genmab has a market cap of $18.54 Billion. This makes Genmab the world's 983th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $18.54 B | -10.82% |
2023 | $20.79 B | -25.6% |
2022 | $27.95 B | 6.75% |
2021 | $26.18 B | -1.86% |
2020 | $26.68 B | 85.08% |
2019 | $14.41 B | 43.77% |
2018 | $10.02 B | -0.52% |
2017 | $10.08 B | 0.47% |
2016 | $10.03 B | 25.41% |
2015 | $8.00 B | 138.74% |
2014 | $3.35 B | 65.01% |
2013 | $2.03 B | 192.75% |
2012 | $0.69 B | 136.2% |
2011 | $0.29 B | -51.56% |
2010 | $0.60 B |
On Apr 24th, 2024 the market cap of Genmab was reported to be: